Fri 12/15/2017 09:10 ET
DJIA24508.6676.770.31%SOLAR24.480.020.08%GOLD1262.004.920.39%Shanghai3136.7734.501.10%
S&P 5002652.010.000.00%BANKS27.690.010.04%OIL57.420.380.66%Nikkei22420.08417.011.86%
NASDAQ6856.530.000.00%SEMI97.650.000.00%US/EU1.180.000.13%Futures2663.757.750.29%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - India Globalization Capital - IGC   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC
  
From: NetworkNewsWire (Rep: 0)Date: 10/18/2017 19:14
Forum: India Globalization Capital - Msg #1226Thread #673959940 (Rec: 0)
NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62 percent. “Based on this and other previously announced compelling data, we are readying IGC-AD1, brand name Hyalolex, in a liquid formulation for commercialization in early 2018,” Ram Mukunda, CEO of IGC, stated in the news release. “We have identified Germany, Canada and certain licensed medical cannabis states in the U.S. for commercialization… Our initial research indicates that there are about 7.8 million patients with AD in these combined markets.” The newly-announced results, when combined with earlier reported data showing that IGC-AD1 reduces Aβ production and inhibits Aβ aggregation without any neuronal toxicity, represent a novel breakthrough toward the treatment of Alzheimer’s, which is known as America’s most expensive disease with an estimated annual cost to the U.S. economy of $236 billion.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreIGC: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.